A 52-year-old man with a history of hepatosplenomegaly and bone pain is found to have a WBC count of 85,000/μL on routine blood work. Peripheral blood smear reveals numerous cells with a 'hairy' or filamentous cytoplasmic projections. Which is the most appropriate confirmatory investigation?

## Clinical Context The combination of marked leukocytosis (WBC 85,000/μL), hepatosplenomegaly, bone pain, and the pathognomonic finding of "hairy cells" (cells with fine cytoplasmic projections) on peripheral blood smear is highly suggestive of hairy cell leukemia (HCL). ## Why Flow Cytometry is the Most Appropriate Confirmatory Investigation **Key Point:** Flow cytometry with specific CD markers is the current gold standard and most appropriate confirmatory investigation for hairy cell leukemia. The characteristic immunophenotype — CD19+, CD20+ (bright), CD11c+, CD25+, CD103+, CD123+ — is virtually pathognomonic for HCL and is recognized as the definitive confirmatory test in modern hematology practice (Harrison's Principles of Internal Medicine, 21st ed.). Hairy cells are clonal B-lymphocytes with a unique surface antigen profile. The co-expression of CD11c, CD25, CD103, and CD123 is highly specific for HCL and distinguishes it from other B-cell lymphoproliferative disorders such as splenic marginal zone lymphoma and B-cell prolymphocytic leukemia. **High-Yield:** Flow cytometry can be performed on peripheral blood, bone marrow aspirate, or splenic tissue, making it versatile and non-invasive. It simultaneously provides immunophenotypic confirmation and quantification of the neoplastic clone. ## Diagnostic Approach for Hairy Cell Leukemia | Investigation | Utility | Current Role | |---|---|---| | Flow cytometry (CD11c, CD25, CD103, CD123) | Gold standard immunophenotyping; highly specific | **First-line confirmatory test** | | TRAP stain | Historically used; positive in HCL | Largely replaced by flow cytometry; less specific (also positive in some other conditions) | | Bone marrow biopsy | Shows "fried egg" pattern; confirms marrow infiltration | Useful when flow cytometry is inconclusive | | Cytogenetics/FISH (BRAF V600E) | Present in ~95% of HCL | Useful for variant HCL or treatment planning | **Clinical Pearl:** While TRAP stain was historically considered the gold standard, it has been largely superseded by flow cytometry in modern practice. TRAP can be positive in other conditions (e.g., B-cell prolymphocytic leukemia, some cases of CLL), reducing its specificity. Flow cytometry with the CD11c/CD25/CD103/CD123 panel is now the preferred confirmatory test per current hematology guidelines (WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 2022). ## Why Flow Cytometry is Superior to Other Tests 1. **Specificity:** The CD11c+/CD25+/CD103+/CD123+ immunophenotype is virtually pathognomonic for HCL. 2. **Sensitivity:** Detects even low levels of circulating hairy cells in peripheral blood. 3. **Non-invasive:** Can be performed on peripheral blood without bone marrow biopsy. 4. **Comprehensive:** Simultaneously confirms B-cell lineage and provides the specific HCL immunophenotype. 5. **Guideline-endorsed:** Recommended as the primary confirmatory test by WHO and major hematology societies. ## Mnemonic: HCL Flow Cytometry Markers **CD11c** — Characteristic monocyte/macrophage marker aberrantly expressed **CD25** — IL-2 receptor alpha; key HCL marker **CD103** — Integrin; highly specific for HCL **CD123** — IL-3 receptor; distinguishes HCL from variant HCL